	B-Cell Remodeling and Regulatory Phenotypes During Acute COVID-19 Are Unaffected by Polyclonal Anti-SARS-CoV-2 Antibody XAV-19. Eur J Immunol Degauque N, Danger R, Mai HL, Cadoux M, Nguyen TV, Tilly G, Raffi F, Guimard T, Lacombe K, Laureillard D, Hocqueloux L, Dubee V, Ader F, Fourgeux C, Poschmann J, Vanhove B, Duvaux O, Gaborit B, Brouard S, POLYCOR study group. PMID: 42745635 [PubMed - indexed for MEDLINE]
	Impact of Prior Exposure to Anisakis simplex Antigens on Immune Response During SARS-CoV-2 Vaccination. Parasite Immunol Cuéllar C, Rodero M, González-Fernández J, Galindo-Regal L, López-Chuliá F, García-Ballesteros C, Fernández-Murga L, Llombart-Cussac A, Domínguez-Márquez MV, Andreu-Ballester JC. PMID: 42745230 [PubMed - indexed for MEDLINE]
	Intrinsic OPTIR imaging and spectroscopy enable label-free monitoring of viral infection in living cells. Anal Bioanal Chem Raghunathan S, Worch K, Krafft C, Deckert V, Burse A, Popp J, Shaik TA. PMID: 42745031 [PubMed - as supplied by publisher]
	Author Correction: A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2. Nat Metab Tong L, Xiao X, Li M, Fang S, Ma E, Yu X, Zhu Y, Wu C, Tian D, Yang F, Sun J, Qu J, Zheng N, Liao S, Tai W, Feng S, Zhang L, Li Y, Wang L, Han X, Sun S, Yang L, Zhong H, Zhao J, Liu W, Liu X, Wang P, Li L, Zhao G, Zhang R, Cheng G. PMID: 42744913 [PubMed - as supplied by publisher]
	Publisher Correction: Design, structure-based optimization and antiviral evaluation of potent inhibitors for the macrodomain Mac1 of SARS-CoV-2. Nat Commun Sandmann M, Tajdar S, Sander S, Ruiz Carrillo D, Ganter B, Fischer C, Ocenas M, Etzold S, Pekarek N, Berger J, Meister TL, Selisko B, Canard B, Watt JM, Baszczy, Potter BV, Garcia Alai M, Henning T, Susanne P, Meier C, Fliegert R. PMID: 42744815 [PubMed - in process]
	Beyond seropositivity: SARS-CoV-2 IgG responses in high-risk COVID-19 patients. J Microbiol Immunol Infect Marsiglia MD, Rovito R, Amendola A, Colzani D, Mariën L, Marchetti G, Borghi E, Tincati C, Bianchi S. PMID: 42744669 [PubMed - as supplied by publisher]
	Insights into vulnerable road user injury trends in the context of the COVID-19 pandemic: Canadian city trends 2012-2022. J Safety Res Rothman L, Howard A, Winters M, Saunders N, Macpherson A, Hagel BE, Macarthur C, HubkaRao T, Pike I, Zubair S, Cloutier MS, Harris MA, Chevrier T, Zanotto M, Fuselli P, Batomen B. PMID: 42744516 [PubMed - indexed for MEDLINE]
	Enhancing crisis resilience for future emergencies: A rapid review of road safety outcomes and reported measures during the COVID-19 pandemic. J Safety Res Lehmann K, Wang YF, Mamri A, Brown TG, Vanlaar W, Batomen B, Ouimet MC, Nazif-Munoz JI. PMID: 42744480 [PubMed - indexed for MEDLINE]
	Mortality Surveillance Learning Module: DurÃ¡n et al (2026), Multiple causes of death data to track trends of mortality from chronic diseases: Insights from the COVID-19 pandemic in Switzerland. Ann Epidemiol Jones J. PMID: 42744417 [PubMed - indexed for MEDLINE]
	Exploring long covid care pathways in the UK NHS: a qualitative study of healthcare professionals' experiences. BMJ Open Daodu L, Raste Y, Allgrove JE, Arrigoni F, Kayyali R. PMID: 42744387 [PubMed - indexed for MEDLINE]
	Employment type and non-compliance with SARS-CoV-2 diagnostic testing: insights from a nationwide seroprevalence study in South Korea. BMJ Open Jang Y, Yoon K, Jo S, Han J, Kim JA, Baek HJ, Jung J, Joo H, Jang Y, Lee JW, Lee SY, Kim DH. PMID: 42744362 [PubMed - indexed for MEDLINE]
	Multifaceted signaling of the cell surface receptor neuropilin-1 (NRP1): pathophysiological roles and therapeutic potential. Gene Aashaq S, Rakhshan R, Rafiq A, Ali M, Beigh MA. PMID: 42744165 [PubMed - as supplied by publisher]
	Marine phlorotannins block SARS-CoV-2 entry via ACE2 and attenuate pulmonary inflammation in K18-hACE2 transgenic mice. Antiviral Res Nagahawatta DP, Jeong SH, Liyanage NM, Jayawardena TU, Hyun JM, Jayawardhana HHACK, Kwon HJ, Jeon YJ. PMID: 42744080 [PubMed - as supplied by publisher]
	PhoSARte: identification of SARS-CoV-2 phosphorylation sites using contrastive learning and protein language models. Brief Bioinform Pham NT, Tran DT, Su Q, Jung Y, Bupi N, Kang D, Lee S, Manavalan B. PMID: 42743972 [PubMed - indexed for MEDLINE]
	Assessing SARS-CoV-2 immune markers in vaccinated asymptomatic adults after household exposure in Canada (AB-PROTECT): a prospective cohort study. Lancet Microbe Kandel C, Breznik JA, Taylor M, Colwill K, Hu Q, Llanes A, Crowl G, Elliott HD, Shi G, Li XA, Lefebvre M, Lee Y, Kurtesi A, Qi F, Delgado-Brand M, Tursun TR, Mailhot G, Tersigni M, Wu Y, Ang JC, Kozak R, Cowbrough B, Benoit JM, McCready J, Powis J, Verschoor CP, Bramson JL, Miller MS, Bowdish DME, Gingras AC, McGeer A. PMID: 42743944 [PubMed - as supplied by publisher]
	COVID-19 vaccine effectiveness in people on immunosuppressive therapies: a systematic review and meta-analysis. Lancet Microbe Stadler E, Khan SR, Elias KM, Egilmezer E, Phetsouphanh C, Hastak P, Hewavisenti RV, Joshi RV, Turner T, Cromer D, Sasson SC, Davenport MP, Khoury DS. PMID: 42743943 [PubMed - as supplied by publisher]
	Programmed ribosomal frameshifting triggers translational stress to promote viral replication. Cell Xavier A, Kolling M, Bourke AM, Mosler T, Prieto-Garcia C, Karaulanov E, Reissland M, Tassetto M, Kim D, Klaassen K, Grikscheit K, Torbica E, Dederer V, Busam J, Kazi R, Olmer R, Pallerla SR, Mathea S, Diefenbacher ME, Zarnack K, Bojkova D, Widera M, Aviner R, Andino R, Ciesek S, Dikic I. PMID: 42743925 [PubMed - as supplied by publisher]
	The Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological, and Immunological Trajectory of COVID-19: Protocol for a Prospective Case-Ascertained and Surveillance Study. JMIR Res Protoc Diergaardt A, Iipumbu E, Netha S, Steenkamp P, Shiweva L, Kizito B, Günther G, Nepolo E, Woldetsadik T, Niemann S, Modongo C, Claassens M. PMID: 42743535 [PubMed - indexed for MEDLINE]
	Building capacity in health systems with and for caregivers: A photovoice protocol. PLoS One Fuentes K, Jacobson D, Birze A, Cadel L, Fierheller D, Marcinow M, Patel B, Vijayakumar A, Zenlea I, Kuluski K, Mansfield E. PMID: 42743355 [PubMed - indexed for MEDLINE]
	R1-32-like public antibodies acquire tolerance to SARS-CoV-2 antigenic drift through somatic hypermutation. PLoS Biol Niu C, Huang X, Yan Q, Liu B, Gao X, Song Y, Wang J, Wang L, Li Z, Zheng H, He P, Huang X, Yuan H, Zou B, Yang Y, Wu F, Yao Y, Habib G, Chen X, Chen L, He J, Yao J, Zhao J, Xiong X. PMID: 42743315 [PubMed - as supplied by publisher]

Articles 1 - 20 / 291229

Page 1 of 14562



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy